Bruce H. KenKnight, Ph.D. - Director

Bruce H. KenKnight, PhD is Vice President of Research and Business Development for Boston Scientific Corporation (BSC), Cardiac Rhythm Management Division and Adjunct Professor of Biomedical Engineering at the University of Minnesota .  Since joining BSC (formerly Guidant) in 1990, Bruce has held various technical and managerial roles of increasing responsibility including Senior Scientist, Principal Scientist and Manager of Tachycardia & Bradycardia Therapy Research.  He was promoted to Director of Heart Failure, Atrial Arrhythmia and Emerging Technology Research in 1999.

After founding the Business Development function at Guidant in 2002, Bruce led the execution of nearly 40 business transactions including private equity investments in early-stage technology companies, strategic alliances, as well as, in-licensing and out-licensing of critical technologies.  He has served on the Board of Directors of 7 private companies and currently is actively engaged with CardioNet, InnerPulse, Remon Medical Technologies and Vesalius Ventures.

Prior to joining Guidant, Bruce worked in various research and development roles with early-stage medical technology companies.  He is an author of 45 peer-reviewed manuscripts, reviews and book chapters as well as nearly 100 conference abstracts in fields relating to cardiac electrophysiology and heart failure.  He is an editorial consultant for the Journal of Cardiovascular Electrophysiology, Heart Rhythm, Cardiovascular Research and the International Journal of Cardiology.

Bruce has been named to the External Advisory Board for Biomedical Engineering at Boston University and the University of Alabama at Birmingham and is a member of the BME Innovation, Design and Entrepreneurship Alliance.  In 2007, he was elected to the College of Fellows of the American Institute of American Institute for Medical and Biological Engineering (AIMBE) and was appointed to the office of Secretary/Treasurer of the Industry Council.

Bruce is named as an inventor on >140 U.S. patents that are issued, allowed or published.  A native of Minnesota , Bruce received his bachelor of science degree in mechanical engineering, master of science and PhD degrees in biomedical engineering from the Institute of Technology at the University of Minnesota in Minneapolis and has completed business management training at the Harvard School of Business and the Kellogg School of Management.


 

Bernard A. Harris, Jr., M.D., M.B.A.
Director

President/Chief Executive Officer
Vesalius Ventures

Pamela R. Jones, M.B.A.
Chief Administrative Officer

Vesalius Ventures

Marsha G. Lamb, M.S.
Vice President of Strategic Initiatives

Vesalius Ventures

Kenneth L. Seymens, M.B.A.
Venture Partner

Vesalius Ventures

Jay H. Sanders, M.D.
Chair, Technology Board

Vesalius Ventures

Robert D. Ulrich, Ph.D.
Chairman/Director

Managing Partner
Vanguard Ventures

Bruce H. KenKnight, Ph.D. - Director
VP of Research & Business Development
Boston Scientific Corp.


Ram Velidi, Ph.D. – Director
Managing Director

Peroba Capital

Batsheva Elran, B.Sc. LL.B. - Director
Managing Partner

Opal Ventures

 

 

 

© 2005 Vesalius Ventures